# Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

> **NCT00394030** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 63 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** GSK716155 subcutaneous injections

## Key facts

- **NCT ID:** NCT00394030
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-16
- **Primary completion:** 2007-03-20
- **Final completion:** 2007-03-20
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2017-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00394030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00394030, "Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00394030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*